ID   E-PR293
AC   CVCL_VV75
DR   Wikidata; Q93533965
RX   PubMed=16815068;
CC   Characteristics: Can be used to screen HIV-1 protease inhibitors. Produces HIV-1 PR fused to GFP in the presence of doxycycline.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Transfected with: UniProtKB; P12947; HIV-1 isolate NY5 pol (PR).
CC   Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP).
CC   Transfected with: UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transfected with: UniProtKB; P06492; Human herpesvirus 1 VP16 (UL28) (with p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V349 ! HEK 293 Tet-Off
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 7
//
RX   PubMed=16815068; DOI=10.1016/j.micinf.2006.02.016;
RA   Fuse T., Watanabe K., Kitazato K., Kobayashi N.;
RT   "Establishment of a new cell line inducibly expressing HIV-1 protease
RT   for performing safe and highly sensitive screening of HIV protease
RT   inhibitors.";
RL   Microbes Infect. 8:1783-1789(2006).
//